ASCL2 contributes to clinical assessments of breast cancer and mediates tumor progression via the interaction with CLDN3

Y Yulong Yin (National Engineering Research Center of Industrial Enzymes) Q Qingjie Meng X Xianghua Liu F Fangshi Xu Y Yiwen Li X Xiaogang Han Q Qianqian Guo (Division of Gastroenterology and Hepatology, Mayo Clinic) Y Yonggang Lv

Article Details

Volume / Issue Vol. 16, Issue 1
Published November 29, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

Y

Yulong Yin

National Engineering Research Center of Industrial Enzymes

Q

Qingjie Meng

X

Xianghua Liu

F

Fangshi Xu

Y

Yiwen Li

X

Xiaogang Han

Q

Qianqian Guo

Division of Gastroenterology and Hepatology, Mayo Clinic

Y

Yonggang Lv